Lilly-partnered start-up raises $65 million for RNA-targeting drugs

Haya Therapeutics aims to test its lead drug candidate in humans with the new funds

May 8, 2025 - 13:31
 0
Lilly-partnered start-up raises $65 million for RNA-targeting drugs
Haya Therapeutics aims to test its lead drug candidate in humans with the new funds